NJHRC Written Testimony to the New Jersey Opioid Settlement Advisory Council Dear Members of the New Jersey Opioid Settlement Advisory Council, It’s widely recognized that we won’t be able to arrest our way out of the overdose crisis and that drug use is a public health issue, not a criminal one. With opioid settlement funds, New … Read more
This checklist is a guide of elements to consider when reviewing the application for authorization and designing your syringe access program.
On Wednesday, public health, recovery, and racial justice organizations sent a letter to the Senate Budget Committee, along with legislative leadership and Governor Murphy, urging them to oppose Senate Bill 3325, which proposes harsh new penalties for fentanyl. The bill will be heard by the Senate Budget Committee at its hearing today at 1pm. “The … Read more
On Thursday, April 27, the U.S. Attorney’s Office District of New Jersey shut down a pain treatment practice in Cherry Hill that was serving 300-400 patients across Camden, Burlington, Ocean, Cape May, & Gloucester Counties.For anyone who uses secondhand prescription medicines in these counties (i.e., not directly from the pharmacy or a script in your … Read more
Yesterday, the US Food and Drug Administration (FDA) approved the first ever over-the-counter form of naloxone. This approval applies only to the 4mg nasal spray manufactured by Emergent Biosolutions, which is significantly more expensive than other more affordable versions, including intramuscular naloxone. In response, New Jersey Harm Reduction Coalition (NJHRC) released the following statement.Jenna Mellor, … Read more
“Just Say No” to Fentanyl Penalty Upgrades Increasing fentanyl penalties will exacerbate the overdose crisis, do nothing to reduce the drug supply or demand, and deepen racial injustice fueled by the War on Drugs. It is time for New Jersey policymakers to “just say no” to the drug war and reject S-3096 and S-3325.New Jersey … Read more
